(Q35595930)

9 August 2017

1 reference

title

Use of monoclonal antibodies in vivo as a therapeutic strategy for alloimmune or autoimmune reactivity: the Besançon experience (English)

1 reference

9 August 2017

P. Herve

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1464420

29 September 2022

E. Racadot

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1464420

29 September 2022

D. Wendling

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1464420

29 September 2022

L. Rumbach

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1464420

29 September 2022

P. Tiberghien

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1464420

29 September 2022

J. Y. Cahn

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1464420

29 September 2022

M. Flesch

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1464420

29 September 2022

J. Wijdenes

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1464420

29 September 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1464420

29 September 2022

publication date

1 October 1992

1 reference

9 August 2017

published in

Immunological Reviews

1 reference

9 August 2017

volume

129

1 reference

9 August 2017

page(s)

31-55

1 reference

Central nervous system myelin: structure, function, and pathology

9 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1992.TB01418.X

Immunologic studies of patients with chronic encephalitis induced by post-exposure Semple rabies vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1992.TB01418.X

Interleukin-6 and the acute phase response

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1992.TB01418.X

Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1992.TB01418.X

Multiple sclerosis: possible immunological mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1992.TB01418.X

Antibodies to myelin-associated glycoprotein (MAG) in the cerebrospinal fluid of multiple sclerosis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1992.TB01418.X

Tumor necrosis factor/cachectin is an effector of skin and gut lesions of the acute phase of graft-vs.-host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1992.TB01418.X

Abnormal distribution of the helper-inducer and suppressor-inducer T-lymphocyte subsets in the rheumatoid joint.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1992.TB01418.X

New diagnostic criteria for multiple sclerosis: guidelines for research protocols

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1992.TB01418.X

Prevention of type II collagen-induced arthritis by in vivo treatment with anti-L3T4

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1992.TB01418.X

Immunoreactive myelin proteolipid protein?like activity in cerebrospinal fluid and serum of neurologically impaired patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1992.TB01418.X

Signal transduction through the CD4 receptor involves the activation of the internal membrane tyrosine-protein kinase p56lck

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1992.TB01418.X

Human recombinant dimeric IL-6 binds to its receptor as detected by anti-IL-6 monoclonal antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1992.TB01418.X

Loss of functional suppression is linked to decreases in circulating suppressor inducer (CD4+ 2H4+) T cells in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1992.TB01418.X

Monoclonal CD4 antibodies after accidental HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1992.TB01418.X

Monoclonal anti-CD4 in arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1992.TB01418.X

Down regulation of T-cell adhesion by CD4

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1992.TB01418.X

Multiple sclerosis: activated cells in cerebrospinal fluid in acute exacerbations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1992.TB01418.X

Therapeutic criteria in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1992.TB01418.X

10.1111/J.1600-065X.1992.TB01418.X

21 January 2018

Identifiers

DOI

1 reference

9 August 2017

1 reference